Advice Pool
#1 in Business Subscribe Email Print

You are here: Home > Health and Fitness > Diabetes > Diabetes Management - The Drug Company Conspiracy

Tags

  • blood
  • market
  • market
  • pharmaceutical companies

  • Links

  • Transform A Tiny Yard To A Perfect Patio In Just 5 Steps
  • Web Design Service With Free Hosting
  • Gift of a Letter
  • Advice Pool - Diabetes Management - The Drug Company Conspiracy

    Turn on the TV or open a magazine and you will find endless advertisements for drugs from pharmaceutical companies. The pharmaceutical companies have huge ad
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    vertising budgets because they are in a billion dollar industry. Treatments for diabetes have played a large role in pharmaceutical revenues. These corporat
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    America drug companies have created helpful treatments for diabetes, but at what cost?

    The cost is that diabetics have become dependent upon these drug trea
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    ments. Plus, they are only treatments and not a cure for diabetes. This leaves many diabetics to wonder why drug companies don’t spend time searching for a
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    ure instead of just promoting treatments. The money these drug companies reel in every day is more than enough to fund studies to find a cure for diabetes.

    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    any drug companies don’t push money into diabetes cure research because if a cure or a way to prevent diabetes is found then their lucrative drugs will become
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    obsolete. This is a greedy mentality that is not in the best interests of people will diabetes. Unfortunately, drug companies have the upper hand because di
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    betes is a disease which we do not choose and sometimes have to manage with their treatments.

    In addition, many drug companies tout new treatments each year
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    hat are in fact a revised version of past treatment options. They bring new drugs to the market in hopes of earning a quick dollar, or millions of dollars, w
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    en in fact it is a new spin on an old treatment. This can be frustrating, misleading, and expensive for diabetes sufferers.

    Drug companies also focus on dia
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    etic aids such as blood glucose monitors, insulin pumps, and insulin pens. Theses products are often recommended in addition to prescription medication. Dru
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    g companies push these products because it means even more money in their pocket. Plus, these products will be used throughout your life so it means a consta
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    t supply of profit for drug companies.

    The sad fact is that drug companies don’t have our best interests at heart. They see dollar signs instead of human fa
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    es. Many bigwigs at the drug companies will continue to capitalize on the increase in the diabetes epidemic. More diabetes sufferers leads to a bigger marke
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    which puts more money in their pockets.

    People with diabetes need to stand up against these drug corporations. We need to remove the stronghold they have u
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    on us. One way to achieve this goal is to change our lifestyle to help prevent diabetes. For example, Type 2 diabetes is often due to or amplified by being
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    verweight. As diabetics we can engage in diabetes prevention by selecting healthy food options, exercising, and reducing weight. These are actions that we c
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    n take without paying a drug company. We can also look to dietary supplements for their benefits on blood sugar.

    Diabetics need to stand up for their rights
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    We need to push to have money spent on publicizing the ways to reverse diabetes as opposed to treatment only. We need to cap the prices on diabetes treatme
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    ts so that they are at a manageable level for diabetes sufferers. Otherwise, the drug companies will live large while we are trying to maintain a normal life


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.advicepool.org.ua/article/240474/advicepool-Diabetes-Management--The-Drug-Company-Conspiracy.html">Diabetes Management - The Drug Company Conspiracy</a>

    BB link (for phorums):
    [url=http://www.advicepool.org.ua/article/240474/advicepool-Diabetes-Management--The-Drug-Company-Conspiracy.html]Diabetes Management - The Drug Company Conspiracy[/url]

    Related Articles:

    Pay Per Click Advertising: How to Design a Good PPC Advert Part I

    Are You More Than A Writer? The Secret To Success No Writing Workshop Will Ever Tell You

    Learn to Control Panic Attacks and Stop Panic Attacks Fast!

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com